POLYMED
Invest with MTF
Invest Now
Invest in Poly Medicure with 3.03X leverage
Performance
- Low
- ₹1,692
- High
- ₹1,742
- 52 Week Low
- ₹1,692
- 52 Week High
- ₹2,938
- Open Price₹1,742
- Previous Close₹1,741
- Volume158,443
Investment Returns
- Over 1 Month -12.4%
- Over 3 Month -12.17%
- Over 6 Month -20.86%
- Over 1 Year -32.8%
Smart Investing Starts Here Start SIP with Poly Medicure for Steady Growth!
Poly Medicure Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 47.6
- PEG Ratio
- 2.1
- Market Cap Cr
- 17,218
- P/B Ratio
- 5.9
- Average True Range
- 43.05
- EPS
- 35.71
- Dividend Yield
- 0.2
- MACD Signal
- -32.91
- RSI
- 25.75
- MFI
- 3.67
Poly Medicure Financials
Poly Medicure Technicals
EMA & SMA
Current Price
₹1,698.70
-41.8
(-2.4%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,823.72
- 50 Day
- ₹1,880.25
- 100 Day
- ₹1,947.44
- 200 Day
- ₹2,041.71
Resistance and Support
1711.03
- R3 1,779.87
- R2 1,761.03
- R1 1,729.87
- S1 1,679.87
- S2 1,661.03
- S3 1,629.87
Poly Medicure Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-08 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & Others | To consider other business matters. per share(50%)Dividend |
| 2025-05-06 | Audited Results & Final Dividend | |
| 2025-02-03 | Quarterly Results & Others | To consider other business matters. per share(50%)Dividend |
| 2024-10-28 | Quarterly Results & ESOP |
Poly Medicure F&O
About Poly Medicure
- NSE Symbol
- POLYMED
- BSE Symbol
- 531768
- Managing Director
- Mr. Himanshu Baid
- ISIN
- INE205C01021
Similar Stocks to Poly Medicure
Poly Medicure FAQs
Poly Medicure share price is ₹1,698 As on 30 December, 2025 | 22:48
The Market Cap of Poly Medicure is ₹17217.9 Cr As on 30 December, 2025 | 22:48
The P/E ratio of Poly Medicure is 47.6 As on 30 December, 2025 | 22:48
The PB ratio of Poly Medicure is 5.9 As on 30 December, 2025 | 22:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.